The Latin America, Middle East and Africa eClinical solutions Market would witness market growth of 17.1% CAGR during the forecast period (2022-2028).
The volume of data created is tremendous as a result of the Internet of Things (IoT) and the digitization of healthcare, and it contains data that can be easily retrieved through electronic data mining, which was previously unattainable with paper records. It is anticipated that eClinical solutions will significantly affect this field. The widespread use of eClinical solutions is mostly owing to the requirement to maintain transparency, remove redundancy, and combat data fraud associated with medical research.
Considering the complexity of data management procedures in diabetic clinical trials and the extensive use of information technology in research, the adoption of clinical data management systems in these trials seems necessary. During clinical trials, a clinical data management system is a piece of software that facilitates data management and helps to reduce errors that can happen when data is managed manually.
Clinical trials that use software solutions experience significant market expansion. Additionally, a growing tendency toward outsourcing clinical trial services to CROs (Contract Research Organizations) and an increase in the number of life sciences companies and CROs are expected to increase. Research efforts in Asian nations are rising in order to create affordable modules or solutions.
The UAE offers a robust healthcare infrastructure as one of the Middle East's most economically advanced and diverse markets. The government of the UAE has made building a top-notch healthcare infrastructure a primary priority, and as a result, the industry has developed and grown considerably over the past few years. The government of UAE has moved swiftly to implement preventative health measures. The UAE's healthcare industry has grown to accommodate both the country's population's changing needs and its ambition to establish itself as a regional center for medical tourism.
The Brazil market dominated the LAMEA eClinical Solutions Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $335.1 Million by 2028. The Argentina market is poised to grow at a CAGR of 17.7% during (2022 - 2028). Additionally, The UAE market would witness a CAGR of 16.7% during (2022 - 2028).
Based on Delivery Mode, the market is segmented into Web-based (on-demand) Model, Licensed enterprise (On-premise) Model and Cloud-based (SaaS) Model. Based on Product, the market is segmented into CDMS/EDC Solutions, CTMS Solutions, Analytics & Reporting Platforms, Safety Solutions, Integration Platforms, RTMS Solutions, eCOA Solutions and Others. Based on Clinical Trials Phase, the market is segmented into Phase III, Phase II, Phase IV and Phase I. Based on End User, the market is segmented into Pharmaceutical & Biopharmaceutical Companies, Academic Research Institutions, Hospitals, Contract Research Organizations, Medical Device Manufacturers and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: The Global eClinical solutions Market is Predict to reach $20.1 Billion by 2028, at a CAGR of 13.6%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Oracle Corporation, Anju Software, Inc., eClinical Solutions LLC, Castor EDC, Signant Health, Dassault Systemes SE, Parexel International Corporation (Phoenix Parentco, Inc.), Clario, BSI Life Sciences (Business Systems Integration AG) and MedNet Solutions
By Delivery Mode
By Product
By Clinical Trials Phase
By End User
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
